Current Month
Article Features
  Bone Cells Suppress Cancer Metastases
Cancer Screening Rates Decline When Patients See Doctors Later in Day
Comparison Between Clinicians’ and Radiologists’ Understanding and Imaging of Breast Pain
Do Physicians Properly Advise Women with Dense Breasts on Cancer Risk?
Elderly Survivors of Three Common Cancers Face Persistent Risk of Brain Metastasis
Fracture Risk Tool Useful in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy
Frequency and Outcomes of New Suspicious Lesions on Breast MRI in Neoadjuvant Therapy
Less-Invasive Mastectomy Safe for More Breast Cancer Patients, Study Finds
Management of Radial Scars Diagnosed on Core Biopsy During Transition to Tomosynthesis
Nipple Reconstruction Techniques Could Be Improved With 3D Scaffolds
Novel Artificial Intelligence Method Predicts Future Risk of Breast Cancer
Obesity Reprograms Immune Cells in Breasts to Promote Tumor Formation
Partial Breast Irradiation Effective Treatment Option for Low-Risk Breast Cancer
Proton Therapy Lowers Risk of Side-Effects Compared to Conventional Radiation
Soy Foods Linked to Fewer Fractures in Younger Breast Cancer Survivors
Technology Better Than Tape Measure for Identifying Lymphedema Risk
Trial Remedies Racial Disparities in Treatment for Early-Stage Lung and Breast Cancer
Utilization and Cancer Yield of BI-RADS3 Lesions Detected on High Risk Screening Breast MRI
Yale Study Identifies How Cancer Drug Inhibits DNA Repair in Cancer Cells

Partial Breast Irradiation Effective Treatment Option for Low-Risk Breast Cancer

Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center.

This randomized, phase 3 study compared whole breast irradiation with partial breast irradiation in a large group of women with stage 0, 1 or 2 breast cancer. More than 4,200 patients were enrolled in the trial as part of NRG Oncology cooperative group clinical trial.

Study results showed that while partial breast irradiation does not produce equivalent cancer control for all breast cancer patients with stage 0, 1 and 2 disease, it should still be considered as an alternative for women with DCIS (ductal carcinoma in situ) and early stage breast cancers deemed "low risk," based on other tumor characteristics.

Read More of the Main Article

Visit the Ezine

Visit the BreastCenter

Visit the Quality Corner